For prescribing information and adverse event reporting, click here

This section of the website is for UK service managers or commissioners only. If you are not a service manager or commissioner, please click here

This website has been commissioned by Ipsen UK and is intended for a UK audience.

Resources

Cervical Dystonia

Dysport® (Clostridium botulinum type A toxin-haemagglutinin complex) therapeutic indications

Dysport® is indicated in adults for symptomatic treatment of spasmodic torticollis

Please click here to see the full therapeutic indications.

Talking Head Videos

Making sense of the changing NHS and funding flows
Making sense of the changing NHS and funding flows
Video 12:15

Judy Willits discusses how the NHS payment scheme has evolved and what the changes could mean for your botulinum toxin services.

DYS-UK-008947 | November 2024

Contact your Ipsen representative

Send request
Resources

To access relevant information about Cervical Dystonia, please confirm the following:

I am a UK Healthcare Professional

This section is for UK healthcare professionals only.
Contains promotional information

I am a UK Healthcare Professional

I am a service manager or commissioner

This section provides information for service managers or commissioners.
Contains promotional information

I am a service manager or commissioner

Adverse events should be reported.
Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in Google Play or Apple App Store. Adverse events should also be reported to Ipsen via email at pharmacovigilance.uk-ie@ipsen.com or phone on 
01753 627777.

I am a member of the general public

This section is for members of the general public.

I am a member of the general public